NCT04790695 2022-01-12
Single Patient Protocol for an NRG1 Fusion Positive Metastatic Pancreatic Cancer Patient Using Seribantumab
Ottawa Hospital Research Institute
Phase 2 Completed
Clinical Trials
4 trialsNCT01151046 2016-05-12
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Merrimack Pharmaceuticals
Phase 2 Completed
NCT01447706 2016-05-12
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Merrimack Pharmaceuticals
Phase 2 Completed
NCT01421472 2016-05-03
A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer
Merrimack Pharmaceuticals
Phase 2 Completed